Randy Rodríguez’s return to the mound has hit a temporary speed bump.
The San Francisco Giants confirmed on Tuesday that the right-handed reliever has been shut down for the remainder of the Arizona Fall League after experiencing discomfort in his surgically repaired right elbow.
While Rodríguez remains on track for Spring Training, the decision to pull him from the Scottsdale Scorpions roster—where he managed just two innings of work—reflects a heightened sense of caution within the Giants’ front office.
“Just being careful,” Giants president of baseball operations Buster Posey told reporters at the General Managers Meetings in Las Vegas on Tuesday. “He had a little bit of elbow pain, and we’re just being cautious with him.”
A bit of news from the GM Meetings: Why Randy Rodríguez likely won't make another appearance in the Arizona Fall League. “Everything went great. … Kind of saw what we needed to see.”https://t.co/wPatAgQ3BQ
The organization faces high stakes. Rodríguez was a revelation in 2025, posting a stellar 1.78 ERA with 67 strikeouts across 50 2/3 innings before a season-ending elbow sprain derailed his momentum. His absence throughout the 2026 campaign left a void in the late innings that the Giants struggled to fill, contributing to a difficult 65-97 finish under manager Tony Vitello.
Managing the Ninth Inning Transition
Looking toward 2027, the Giants must balance high-pressure production with long-term health. Posey expressed a clear preference for easing Rodríguez back into the rotation rather than immediately reinstating him as the primary closer. The goal is to monitor his workload carefully, though the executive acknowledged that organizational needs could dictate a change in plans.
The bullpen situation is changing, particularly with the looming Nov. 20 deadline to tender contracts to arbitration-eligible players. Camilo Doval, who returned to the organization via waivers from the Pittsburgh Pirates in late September, finished his 2026 campaign on a high note by striking out four batters over two scoreless innings. Whether Doval remains a central figure in the bullpen mix is a decision the club must finalize in the coming days.
Randy Rodríguez made three appearances in the Arizona Fall League to aid his recovery from Tommy John surgery https://t.co/zXyXc40jwQ
The Cost of Free Agent Reinforcements
With the bullpen identified as a primary weakness, the Giants are naturally surveying the free-agent market. High-profile arms like Adrian Morejon and David Bednar are available, yet both carry the “qualified” tag, requiring the surrender of draft picks for any team that signs them. For a front office that already sacrificed second- and fifth-round selections to secure Willy Adames, this presents a difficult strategic hurdle.
“I think it’s going to be harder for us,” Posey said regarding the pursuit of qualified free agents. “I do think our system’s in a better spot, but ideally, we’re able to continue to add talent through the draft, through the international signings. Those high picks are important.”
This organizational philosophy highlights the tension between the desire to contend and the necessity of long-term development. While the Giants have invested heavily in veterans such as Rafael Devers, Matt Chapman, and Jung Hoo Lee, the farm system’s top-tier talent—including prospects like Josuar Gonzalez, Luis Hernández, and Jackson Flora—is still years away from making an impact at the major league level.
Balancing 2027 Ambitions
The rotation also faces scrutiny, as it currently lacks established depth beyond Logan Webb and Landen Roupp. While free agents like Tarik Skubal sit at the top of the market, Posey’s recent comments suggest the club may be hesitant to engage in another aggressive spending spree.
The organization is currently in a state of transition, attempting to field a competitive roster while acknowledging the gap between their current big-league personnel and the arrival of their next wave of prospects.
“You’re trying to thread the needle, right?” Posey said. “You’re trying to thread the needle of having the big-league team in a spot where they can win but also understanding that some of our top players in our system are probably two or three years away. It’s a balancing act.”
As the Giants weigh their options, the focus remains on the health of their core contributors.
How do you think the Giants should prioritize their limited draft capital this winter? Is it worth sacrificing more picks to secure a proven closer, or is the team better off betting on the internal recovery of arms like Rodríguez?
